Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05685576
Other study ID # UAlexandriaDentSurg22
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 25, 2022
Est. completion date March 5, 2023

Study information

Verified date May 2023
Source University of Alexandria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with long span, narrow edentulous ridge in the posterior mandible underwent piezotomed ridge splitting and osseodensification with simultaneous implant placement.


Description:

This study is a single arm clinical trial. Patients of both genders, who are indicated for ridge splitting, were recruited from the outpatient clinic, Faculty of dentistry, Alexandria University. The PICO question: "What is the effect of piezotomed ridge splitting and osseodensification on implant placement in narrow posterior mandibular ridges?" Ethical approval for the study was obtained from the regional Ethical Review Board of the Faculty of Dentistry. All patients were informed about the procedure details, and each participant signed a written consent. Ridge expansion was accomplished by piezotomed ridge splitting and osseodensification. Simultaneous implant placement was done in the same procedure. Implant stability was assessed. Also, bone width gained and bone density were measured around the dental implants using cone beam computed tomography.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date March 5, 2023
Est. primary completion date March 4, 2023
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with good oral hygiene - Patients with long-span, narrow posterior edentulous mandibular area - Age limit range [25 - 66 years] - Patients who accept to participate in the study - Minimum height 10mm from the crest of the ridge till the upper border of inferior alveolar canal - Minimum ridge thickness = 3mm at the crestal region - If the patient is diabetic, should be controlled. Exclusion Criteria: - Immunosuppressive/ autoimmune disease patients - Patients with osteoporosis - Lack of sufficient amount of keratinizing mucosa at the crest of the edentulous saddle - Patients with bleeding disorder disease - Ridge width less than 3 mm - Smokers - Patients having periodontal disease - The presence of a pathological lesion in the area of ridge splitting

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Piezotomed ridge splitting and osseodensification
Ridge expansion using piezotomed ridge splitting and osseodensification

Locations

Country Name City State
Egypt Faculty of Dentistry Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Lydia Nabil

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The score of primary implant stability - Primary stability of the implants is measured using:
insertion torque and
resonance frequency analysis by Osstell ISQ device (Osstell ISQ, W&H, Sweden)
immediately at time of implant insertion
Secondary The width of bone gained Width of bone gained at the crest of the ridge is measured by cone beam computed tomography in mm 3 months postoperative
Secondary The mean bone density around dental implants The mean bone density around dental implants is measured by cone beam computed tomography in grey scale values 3 months postoperative
See also
  Status Clinical Trial Phase
Completed NCT03166475 - Ridge Preservation With Provisional Ovoid Pontic N/A
Recruiting NCT06190860 - Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers N/A
Completed NCT04243421 - Marginal Bone and Soft Tissue Alterations After Use of OsseoSpeed EV Profile Implants N/A